Skip to main content
. 2018 Sep 21;115(38):628–635. doi: 10.3238/arztebl.2018.0628

Figure 1.

Figure 1

Management of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) (modified from Clemens et al.: Clin Plast Surg 2015; 42: 605–13 [28])

ALK, Anaplastic lymphoma kinase; BfARM, Federal Institute for Drugs and Medical Devices; DGPRÄC, German Society of Plastic, Reconstructive, and Aesthetic Surgeons; FDA, Food and Drug Administration; PET-CT, positron-emission tomography/computed tomography